Analysis of the completeness of the russian market of over-the-counter medicines for the treatment of neurotic disorders
| Autor: | T. A. Oleynikova, E. S. Barybina |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | REMEDIUM. 26:308-311 |
| ISSN: | 2658-3534 1561-5936 |
| Popis: | Mental health is an integral part and the most important component of human health. However, today half of the population of our country has signs of its violation, of which about 5% need professional psychiatric care. Mental disorders lead to a significant decrease in the quality of life, disability of the population, as well as prolonged and recurrent disability. In recent years, the COVID-19 pandemic has caused significant negative consequences for mental health. According to research data in 2020 every third resident of Russia complained of symptoms of depression. Fear, anxiety, depression associated with the introduction of restrictive measures and self-isolation have led to the emergence of chronic stress in the population, which is one of the harbingers of the development of mental disorders. In 2022, the deterioration of mental health is noted against the background of the current political situation in the world. Frequent manifestations of stress lead to various psychoemotional disorders (anxiety, increased irritability, neurosis, sleep disorders, etc.). To avoid these consequences, drugs of various pharmacological groups (sedatives, nootropic, adaptogens, antidepressants and others) are used in the complex therapy of anxiety disorders. Within the framework of the concept of responsible self-treatment, the therapy of these disorders is carried out with over-the-counter medications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|